Skip to content
Screener
Q4 '26Q3 '26Q2 '26Q1 '26Q4 '25
$3.71M+111%$3.71M+111%$3.71M+111%$3.71M+111%$1.75M—
$3.1M+110%$3.1M+110%$3.1M+110%$3.1M+110%$1.48M—
$604.56K+119%$604.56K+119%$604.56K+119%$604.56K+119%$276.3K—
16.3%+0.6pp16.3%+0.6pp16.3%+0.6pp16.3%+0.6pp15.8%—
$1.37M+96.2%$1.37M+96.2%$1.37M+96.2%$1.37M+96.2%$699.48K—
$124.85K-49.5%$124.85K-49.5%$124.85K-49.5%$124.85K-49.5%$247.29K—
$307.38K+239%$307.38K+239%$307.38K+239%$307.38K+239%$90.75K—
$1.8M+74.0%$1.8M+74.0%$1.8M+74.0%$1.8M+74.0%$1.04M—
-$1.2M-57.7%-$1.2M-57.7%-$1.2M-57.7%-$1.2M-57.7%-$761.21K—
-32.4%+11.0pp-32.4%+11.0pp-32.4%+11.0pp-32.4%+11.0pp-43.4%—
$3.96K—$3.96K—$3.96K—$3.96K———
-$3.04M-58.8%-$3.04M-58.8%-$3.04M-58.8%-$3.04M-58.8%-$1.91M—
-$3.04M-58.8%-$3.04M-58.8%-$3.04M-58.8%-$3.04M-58.8%-$1.91M—
-82.1%+27.1pp-82.1%+27.1pp-82.1%+27.1pp-82.1%+27.1pp-109.2%—
-$2,027.07-58.8%-$2,027.07-58.8%-$2,027.07-58.8%-$2,027.07-58.8%-$1,276.61—
-$1.2M-57.8%-$1.2M-57.8%-$1.2M-57.8%-$1.2M-57.8%-$759.65K—
-32.3%+11.0pp-32.3%+11.0pp-32.3%+11.0pp-32.3%+11.0pp-43.3%—
-$1.2M-57.7%-$1.2M-57.7%-$1.2M-57.7%-$1.2M-57.7%-$761.21K—

FAQ

What is Exascale Labs Holdings Inc.'s revenue?
Exascale Labs Holdings Inc. (XLAB) generated $14.8M in revenue over the trailing twelve months, up 111.3% year over year.
Is Exascale Labs Holdings Inc. profitable?
Exascale Labs Holdings Inc. is not currently profitable: it reported a net loss of $12.2M over the trailing twelve months, a -82.1% net margin.
What are Exascale Labs Holdings Inc.'s profit margins?
Gross margin is 16.3% and operating margin is -32.4%, with a -82.1% net margin.
What is Exascale Labs Holdings Inc.'s earnings per share?
Exascale Labs Holdings Inc.'s diluted EPS over the trailing twelve months is $-8108.26.
Where does Exascale Labs Holdings Inc.'s income statement data come from?
Every line is extracted from Exascale Labs Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.